The discovery could speed up new cancer drugs and make them cheaper to produce, a researcher told Newsweek.
Takeda will pay Insilico to use its proprietary Pharma.AI platform to advance drug candidates across several therapeutic ...
Sofinnova Investments’ Jim Healy says biotech innovation is thriving but is skeptical about artificial intelligence’s ability ...
The megadeal is expected to close in the second quarter after a key antitrust waiting period has expired. By Georg Szalai Global Business Editor The planned merger of Discovery and AT&T’s WarnerMedia ...
Artificial intelligence is reshaping nearly every industry, but some of its biggest opportunities are emerging far from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results